Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
PPH Stock Summary
Top 10 Correlated ETFs
PPH
In the News

Pharma ETFs in Focus Post Q3 Earnings
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.

Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
If you're interested in broad exposure to the Healthcare - Pharma segment of the equity market, look no further than the VanEck Pharmaceutical ETF (PPH), a passively managed exchange traded fund launched on 12/20/2011.

PPH: A 'Shot In The Arm' For Investors Looking To Capitalize On Recent Pharmaceutical Advances
VanEck Pharmaceutical ETF has had the strongest one-year performance of four major pharmaceutical ETF competitors due to its unique mix of Novo Nordisk, Eli Lilly, and Johnson & Johnson. Eli Lilly, PPH's top holding, saw a 28% increase in Q2 revenue from its Mounjaro injection, a treatment for Type 2 diabetes. Recent medical treatments such as Ozempic and Wegovy are expected to drive $3.3 billion and $1.1 billion, respectively in revenue for Novo Nordisk in Q3 2023, PPH's second-largest holding.

PPH: GLP-1 Companies And Large-Cap Value Pharma Make For A Compelling Portfolio
Eli Lilly is a mega-cap stock in the Health Care sector that has performed well in 2023, and it's the top holding in the VanEck Pharmaceutical ETF. I have a buy rating on the low-cost and style & geographically-diverse ETF. PPH offers a higher income compared to owning an S&P 500 index fund, but it carries technical risks and, but is top-heavy.

Disruptive Tech Theme of the Week: Weight Loss Revolution
According to the latest CDC National Diabetes Statistics Report, more than 37 million people have diabetes in the U.S., or 11.3% of the population. The statistics for obesity are also dismal, as the World Health Organization reports the global obesity count at more than 1 billion.

Weight Loss Drugs Could Prove Potent for PPH
Ozempic commercials are, at this point, ubiquitous and while that's an anecdotal example, it also represents confirmation that obesity drugs are the next big thing in the pharmaceuticals industry.

Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
The VanEck Pharmaceutical ETF (PPH) was launched on 12/20/2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity market.

6 Best-Performing ETFs of Last Week
Wall Street delivered a mixed performance last week.

Pharma ETFs in Focus Post Q2 Earnings
Second-quarter earnings beat ratio of 86.6% and revenue beat ratio of 84.9% for the healthcare sector are impressive.

Cautious on Big Tech & AI? Try These Value-Focused Sector ETFs
Value-focused investing comes to rescue if high-growth sectors fail for some reasons.
PPH Financial details
PPH Financial Performance
PPH Frequently Asked Questions
What is VanEck Vectors Pharmaceutical ETF stock symbol ?
VanEck Vectors Pharmaceutical ETF is a US stock and trading under the symbol PPH
What is VanEck Vectors Pharmaceutical ETF stock quote today ?
VanEck Vectors Pharmaceutical ETF stock price is $78.4347 today.
Is VanEck Vectors Pharmaceutical ETF stock public?
Yes, VanEck Vectors Pharmaceutical ETF is a publicly traded company.